Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |